Skip to main content
. 2020 Apr;12(2):148–155.

Table 3.

The effect of CFO and L. casei WB 315 on HDL, LDL, Cholesterol

Treatment HDL (%) ± SD LDL (%) ± SD Cholesterol (mg/dL) ± SD
P0: 0% L. casei WB 315 + 0% CFO 8.68a ± 0.80 88.19d ± 0.78 112.25d ± 1.26
P1: 0.5% L. casei WB 315 + 0% CFO 13.32b ± 0.74 83.90c ± 0.83 108.60c ± 1.00
P2: 0% L. casei WB 315 + 1% CFO 22.38c ± 0.78 64.24b ± 0.78 104.53b ± 0.96
P3: 0.5% L. casei WB 315 + 1% CFO 28.05d ± 0.82 57.51a ± 0.82 86.87a ± 0.78
(a, b, c)

Means in the same column with the different superscript are significantly different at (p<0.05).